Motus GI Holdings (Motus GI Holdings) Forward Dividend Yield % : 0.00% (As of Jun. 02, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Motus GI Holdings Forward Dividend Yield %?

As of today (2024-06-02), the Forward Annual Dividend Yield of Motus GI Holdings is 0.00%.

As of today (2024-06-02), the Trailing Annual Dividend Yield of Motus GI Holdings is 0.00%.

MOTS's Forward Dividend Yield % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 1.94
* Ranked among companies with meaningful Forward Dividend Yield % only.

Motus GI Holdings's Dividends per Share for the three months ended in Mar. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Motus GI Holdings's Forward Dividend Yield %

For the Medical Devices subindustry, Motus GI Holdings's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Motus GI Holdings's Forward Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Motus GI Holdings's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Motus GI Holdings's Forward Dividend Yield % falls into.

Motus GI Holdings Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Motus GI Holdings (OTCPK:MOTS) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Motus GI Holdings Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Motus GI Holdings's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Motus GI Holdings (Motus GI Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Motus GI Holdings Inc (OTCPK:MOTS) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1301 East Broward Boulevard, 3rd Floor, Fort Lauderdale, FL, USA, 33301

Website

https://www.motusgi.com

Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the "FDA") to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal ("GI") endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.

Executives

Orchestra Biomed Holdings, Inc.	10 percent owner	150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Scott Durbin	director	PO BOX 376, ANN ARBOR MI 48106
Elad Amor	officer: Chief Accounting Officer	MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Ravit Ram	officer: Chief Financial Officer	MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Timothy P. Moran	director, officer: Chief Executive Officer	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Andrew Lawrence Taylor	officer: Chief Financial Officer	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Mark Pomeranz	director, officer: President and COO	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Sonja Nelson	director	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BOULEVARD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Oracle Partners Lp	other: * See Remarks	200 GREENWICH AVE, 3RD FL, GREENWICH CT 06830
Larry N Feinberg	other: * See Remarks	C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Perceptive Life Sciences Master Fund Ltd	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Darren Sherman	director	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
David P Hochman	director, other: Chairman of the Board	15 WESTON HILL RD., RIVERSIDE CT 06878
Nussbaum Samuel R Md	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Shervin J Korangy	director	850 PARK AVENUE, APT. 12B, NEW YORK NY 10075